Literature DB >> 15809992

A Markov model approach shows a large variation in the length of S phase in MCF-7 breast cancer cells.

Sara Larsson1, Maria Johansson, Stina Oredsson, Ulla Holst.   

Abstract

BACKGROUND: The potential doubling time of a tumor has been suggested to be a measurement of tumor aggressiveness; therefore, it is of interest to find reliable methods to estimate this time. Because of variability in length of the various cell cycle phases, stochastic modeling of the cell cycle might be a suitable approach.
METHODS: The relative movement curve and the DNA synthesis time were estimated by using local polynomial regression methods. Further, the rate of nucleotide incorporation was estimated by using a Markov pure birth process with one absorbing state to model the progression of the DNA distribution through S phase.
RESULTS: An estimate of the DNA synthesis time, with confidence intervals, was obtained from the relative movement curve. The Markov approach provided an estimate of the distribution of the time to complete S phase given the initial distribution. Using the Markov approach we also made an estimate of the mean number of active replicons during S phase.
CONCLUSIONS: A Markov pure birth process has shown to be useful to model the progression of cells through S phase and to increase knowledge about the variability in the length of S phase and a large variation is shown. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809992     DOI: 10.1002/cyto.a.20125

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  2 in total

Review 1.  S Phase Duration Is Determined by Local Rate and Global Organization of Replication.

Authors:  Avraham Greenberg; Itamar Simon
Journal:  Biology (Basel)       Date:  2022-05-07

2.  Flow-based cytometric analysis of cell cycle via simulated cell populations.

Authors:  M Rowan Brown; Huw D Summers; Paul Rees; Paul J Smith; Sally C Chappell; Rachel J Errington
Journal:  PLoS Comput Biol       Date:  2010-04-15       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.